This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Canine Parainfluenza Virus (CPIV) Nucleoprotein Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for canine parainfluenza virus nucleoprotein. It is affinity purified by protein A. It can be applied to ELISA, IFA and WB assays of canine parainfluenza virus nucleoprotein.
Specifications
Target Information
Canine parainfluenza virus (CPIV), a member of the Paramyxoviridae family, is a significant respiratory pathogen in dogs. The nucleoprotein (NP) of CPIV is a vital structural component that tightly binds to the viral RNA genome, forming the helical nucleocapsid. This complex is crucial for the protection of the viral genetic material and its replication within the host cell. The NP of CPIV is a potential target for antiviral therapies due to its essential role in the viral life cycle. Inhibiting the function of the NP could impede the virus's ability to replicate its RNA, thereby limiting viral propagation. Additionally, the NP is an immunogenic protein that can elicit an immune response, making it a candidate for inclusion in vaccines.
Shipping and Storage
This product is shipped with wet ice packs. Store at -20°C on receipt (up to 24 months). Avoid exposure to light. Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Cordisco, Marco, et al. "Canine parainfluenza virus infection in a dog with acute respiratory disease." Veterinary Sciences 9.7 (2022): 346.